Suchergebnisse - "Schokker, Sandor"

PubPharm (15)

1

Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2022

von van Velzen, M. | Creemers, A. | van den Ende, T. | +11

2

Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer

enthalten in: Gastric cancer | 2022

von van Velzen, M. | Creemers, A. | van den Ende, T. | +11

3

Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer

enthalten in: Gastric cancer | 2022

von van Velzen, M. | Creemers, A. | van den Ende, T. | +11

4

A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT)

enthalten in: Therapeutic advances in medical oncology | 2022

von Stroes, C. | Schokker, S. | Khurshed, M. | +18

5

Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma : A Single-arm Phase II Feasibility Trial (PERFECT)

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von van den Ende, T. | de Clercq, N. | van Berge Henegouwen, M. | +19

CommentIn: Clin Cancer Res. 2021 Jun 15;27(12):3269-3271. - PMID 33824165

6

A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOX

enthalten in: Cancers | 2021

von Stroes, C. | Schokker, S. | Molenaar, R. | +17

7

Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma

enthalten in: International journal of cancer | 2020

von Strijker, M. | Soer, E. | de Pastena, M. | +23

8

Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2-Positive Esophageal Adenocarcinoma : TRAP Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2020

von Stroes, C. | Schokker, S. | Creemers, A. | +22

9

Development and validation of an LC-MS/MS method for simultaneous quantification of co-administered trastuzumab and pertuzumab

enthalten in: mAbs | 2020

von Schokker, S. | Fusetti, F. | Bonardi, F. | +3

10

Quality of Life During Palliative Systemic Therapy for Esophagogastric Cancer : Systematic Review and Meta-Analysis

enthalten in: Journal of the National Cancer Institute | 2020

von van Kleef, J. | Ter Veer, E. | van den Boorn, H. | +9